Acumen Pharmaceuticals, Inc. (ABOS) Misses Q3 EPS by 14c
Tweet
Share
E-mailGet Alerts ABOS Hot Sheet
Join SI Premium – FREE
Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) reported Q3 EPS of ($0.50), $0.14 worse than the analyst estimate of ($0.36).
For earnings history and earnings-related data on Acumen Pharmaceuticals, Inc. (ABOS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NPR retracts story about Justice Alito retiring from Supreme Court
- Trump: SCOTUS birthright citizenship ruling 'too bad'
- Supreme Court rules against order limiting birthright citizenship
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
